Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H15NO3S |
| Molecular Weight | 265.328 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)[C@H](N1SC2=C(C=CC=C2)C1=O)C(O)=O
InChI
InChIKey=FUSYFEXGXRDJNB-KWQFWETISA-N
InChI=1S/C13H15NO3S/c1-3-8(2)11(13(16)17)14-12(15)9-6-4-5-7-10(9)18-14/h4-8,11H,3H2,1-2H3,(H,16,17)/t8-,11-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374. | 2001-02 |
|
| 2,2'-Dithiobisbenzamides and 2-benzisothiazolones, two new classes of antiretroviral agents: SAR and mechanistic considerations. | 1997-05 |
|
| The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. | 1997-02 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID3047261
Created by
admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
|
PRIMARY | |||
|
462368
Created by
admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
|
PRIMARY | |||
|
177785-47-6
Created by
admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
|
PRIMARY | |||
|
103QB0867Q
Created by
admin on Mon Mar 31 18:00:32 GMT 2025 , Edited by admin on Mon Mar 31 18:00:32 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
